Volume 22, Issue 2 (Pajouhan Scientific Journal, Spring 2024)
Pajouhan Sci J 2024, 22(2): 119-127 |
Back to browse issues page
Ethics code: IR.UMSHA.REC.1401.863
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jamali Delfan R, Heshmati A, Zanganeh M, Sharifi A. Assessment of Growth Indices in Children and Adolescents with Phenylketonuria in Hamadan City, 2023. Pajouhan Sci J 2024; 22 (2) :119-127
URL: http://psj.umsha.ac.ir/article-1-1094-en.html
URL: http://psj.umsha.ac.ir/article-1-1094-en.html
1- Student Research Committee, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2- Department of Nutrition and Food Hygiene, Nutrition Health Research Center, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3- Clinical Research Center, Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
4- Department of Nutrition and Food Hygiene, Nutrition Health Research Center, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran ,a.sharifi1983@gmail.com
2- Department of Nutrition and Food Hygiene, Nutrition Health Research Center, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3- Clinical Research Center, Besat Hospital, Hamadan University of Medical Sciences, Hamadan, Iran
4- Department of Nutrition and Food Hygiene, Nutrition Health Research Center, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran ,
Abstract: (1645 Views)
Background and Objectives: Dietary restrictions in phenylketonuria (PKU) can prevent children’s normal growth, and compensatory intake of carbohydrates and fats can cause excessive weight gain. This study aimed to investigate some growth indicators in PKU patients aged 6 months to 18 years in Hamadan City in 2023.
Materials and Methods: In this cross-sectional analytical study, the height, weight, and age of all patients ranging in age from 6 months to 18 years, who were registered at the PKU Center of Besat Hospital in Hamedan, were measured and recorded. Body mass index (BMI) was calculated using height and weight information. In addition, the corresponding z-scores were calculated using the online growth calculator software. Z-score values were classified into five levels using World Health Organization criteria.
Results: In this study, 80 PKU patients (including 44 girls and 36 boys) were examined. The average age, as well as the average Z-score of height, weight, and BMI for age, were not significantly different in boys and girls. Moreover, 7.5% of children were underweight, 1.3% were severely underweight, 10% were stunted, and 2.5% were severely stunted. Ten percent of children were severely wasted and 6.3% were wasted. On the other hand, 11.3% were overweight. None of these children were obese.
Conclusion: In addition to controlling the dietary intake of phenylalanine, it is necessary to continuously monitor the growth indicators of these children and also to control the intake of calories, macronutrients, and micronutrients accurately based on the child's needs.
Materials and Methods: In this cross-sectional analytical study, the height, weight, and age of all patients ranging in age from 6 months to 18 years, who were registered at the PKU Center of Besat Hospital in Hamedan, were measured and recorded. Body mass index (BMI) was calculated using height and weight information. In addition, the corresponding z-scores were calculated using the online growth calculator software. Z-score values were classified into five levels using World Health Organization criteria.
Results: In this study, 80 PKU patients (including 44 girls and 36 boys) were examined. The average age, as well as the average Z-score of height, weight, and BMI for age, were not significantly different in boys and girls. Moreover, 7.5% of children were underweight, 1.3% were severely underweight, 10% were stunted, and 2.5% were severely stunted. Ten percent of children were severely wasted and 6.3% were wasted. On the other hand, 11.3% were overweight. None of these children were obese.
Conclusion: In addition to controlling the dietary intake of phenylalanine, it is necessary to continuously monitor the growth indicators of these children and also to control the intake of calories, macronutrients, and micronutrients accurately based on the child's needs.
Type of Study: Research Article |
Subject:
Health Sciences
Received: 2024/05/14 | Accepted: 2024/05/29 | Published: 2024/07/31
Received: 2024/05/14 | Accepted: 2024/05/29 | Published: 2024/07/31
References
1. Aldámiz-Echevarría L, Bueno MA, Couce ML, Lage S, Dalmau J, Vitoria I, et al. Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients. Clin Nutr. 2014;33(4):702-17. [DOI:10.1016/j.clnu.2013.09.011] [PMID]
2. Rodrigues KF, Yong WTL, Bhuiyan MSA, Siddiquee S, Shah MD, Venmathi Maran BA. Current Understanding on the Genetic Basis of Key Metabolic Disorders: A Review. Biology. 2022;11(9). [DOI:10.3390/biology11091308] [PMID]
3. Elhawary NA, AlJahdali IA, Abumansour IS, Elhawary EN, Gaboon N, Dandini M, et al. Genetic etiology and clinical challenges of phenylketonuria. Hum Genomics. 2022;16(1):22. [DOI:10.1186/s40246-022-00398-9] [PMID]
4. Shoraka HR, Haghdoost AA, Baneshi MR, Bagherinezhad Z, Zolala F. Global prevalence of classic phenylketonuria based on Neonatal Screening Program Data: systematic review and meta-analysis. Clin Exp Pediatr.2020;63(2):34-43. [DOI:10.3345/kjp.2019.00465] [PMID]
5. Shokri M, Karimi P, Zamanifar H, Kazemi F, Badfar G, Azami M. Phenylketonuria screening in Iranian newborns: a systematic review and meta-analysis. BMC Pediatr. 2020;20(1):352. [DOI:10.1186/s12887-020-02230-6] [PMID]
6. Singh RH, Rohr F, Frazier D, Cunningham A, Mofidi S, Ogata B, et al. Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genet Med. 2014;16(2):121-31. [DOI:10.1038/gim.2013.179] [PMID]
7. [Consensus statement on dietary treatment and nutritional management for phenylalanine hydroxylase deficiency]. Zhonghua er ke za zhi = Chinese journal of pediatrics. 2019;57(6):405-9.
8. de Baulny HO, Abadie V, Feillet F, de Parscau L. Management of phenylketonuria and hyperphenyl-alaninemia. The Journal of nutrition. 2007;137(6):1561S-3S. [DOI:10.1093/jn/137.6.1561S] [PMID]
9. Demirkol M, Giżewska M, Giovannini M, Walter J. Follow up of phenylketonuria patients. Molecular Genetics and Metabolism. 2011;104:S31-S9. [DOI:10.1016/j.ymgme.2011.08.005] [PMID]
10. Dokoupil K, Gokmen-Ozel H, Lammardo AM, Motzfeldt K, Robert M, Rocha JC, et al. Optimising growth in phenylketonuria: Current state of the clinical evidence base. Clinical Nutrition. 2012;31(1):16-21. [DOI:10.1016/j.clnu.2011.09.001] [PMID]
11. Enns GM, Koch R, Brumm V, Blakely E, Suter R, Jurecki E. Suboptimal outcomes in patients with PKU treated early with diet alone: Revisiting the evidence. Mol Genet Metab. 2010;101(2):99-109. [DOI:10.1016/j.ymgme.2010.05.017] [PMID]
12. Burrage LC, McConnell J, Haesler R, O'Riordan MA, Sutton VR, Kerr DS, et al. High prevalence of overweight and obesity in females with phenylketonuria. Mol Genet Metab. 2012;107(1):43-8. [DOI:10.1016/j.ymgme.2012.07.006] [PMID]
13. Huemer M, Huemer C, Möslinger D, Huter D, Stöckler-Ipsiroglu S. Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis. 2007;30(5):694-9. [DOI:10.1007/s10545-007-0549-3] [PMID]
14. Allen JR, McCauley JC, Waters DL, O'Connor J, Roberts DC, Gaskin KJ. Resting energy expenditure in children with phenylketonuria. Am J Clin Nutr. 1995;62(4):797-801. [DOI:10.1093/ajcn/62.4.797] [PMID]
15. Dobbelaere D, Michaud L, Debrabander A, Vanderbecken S, Gottrand F, Turck D, et al. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. Journal of inherited metabolic disease. 2003;26(1):1-11. [DOI:10.1023/A:1024063726046] [PMID]
16. Belanger-Quintana A, Martínez-Pardo M. Physical development in patients with phenylketonuria on dietary treatment: a retrospective study. Mol Genet Metab. 2011;104(4):480-4. [DOI:10.1016/j.ymgme.2011.08.002] [PMID]
17. Scaglioni S, Verduci E, Fiori L, Lammardo AM, Rossi S, Radaelli G, et al. Body mass index rebound and overweight at 8 years of age in hyperphenylalaninaemic children. Acta paediatrica. 2004;93(12):1596-600. [DOI:10.1111/j.1651-2227.2004.tb00849.x] [PMID]
18. White JE, Kronmal RA, Acosta PB. Excess weight among children with phenylketonuria. J Am Coll Nutr. 1982;1(3):293-303. [DOI:10.1080/07315724.1982.10718998] [PMID]
19. Sailer M, Elizondo G, Martin J, Harding CO, Gillingham MB. Nutrient intake, body composition, and blood phenylalanine control in children with phenylketonuria compared to healthy controls. Mol Genet Metab Rep. 2020;23:100599. [DOI:10.1016/j.ymgmr.2020.100599] [PMID]
20. Pinto A, Adams S, Ahring K, Allen H, Almeida MF, Garcia-Arenas D, et al. Early feeding practices in infants with phenylketonuria across Europe. Mol Genet Metab Rep. 2018;16:82-9. [DOI:10.1016/j.ymgmr.2018.07.008] [PMID]
21. World Health O. WHO child growth standards: training course on child growth assessment. 2008.
22. Motedayen M, Dousti M, Sayehmiri F, Pourmahmoudi AA. An Investigation of the Prevalence and Causes of Malnutrition in Iran: a Review Article and Meta-analysis. Clin Nutr Res. 2019;8(2):101-18. [DOI:10.7762/cnr.2019.8.2.101] [PMID]
23. Eshraghi P AABAHS. Evaluation of Nutritional Status and Growth in Phenylketonuria Patients in Mazandaran Province Iran. J Babol Univ Med Sci. 2011;13(5):58-62.
24. Mona Z, Mahtab T, Masoud Z, Majid K, Majid A. Anthropometric Assessment and some of Contributing Factors in Control of Phenylketonuria Patients in Khuzestan Province. Jundishapur Scientific Medical Journal. 2014;13(1):21-30.
25. Pena MJ, de Almeida MF, van Dam E, Ahring K, Bélanger-Quintana A, Dokoupil K, et al. Protein substitutes for phenylketonuria in Europe: access and nutritional composition. Eur J Clin Nutr. 2016;70(7):785-9. [DOI:10.1038/ejcn.2016.54] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences.
Published by UMSHA Press
Journal Tel: +98 81 38380090
Publisher Tel: +98 81 38382022
Website: https://psj.umsha.ac.ir/
Email: psj@umsha.ac.ir
